Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06792864 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of 3D Bone Matrix in Cranioplasty

Study acronym: OSTEOPRINTCR
StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 27, 2025 (before its estimated March 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The objective of this clinical trial is to evaluate the effectiveness of a 3D bone scaffold in relation to a scaffold formed by PCL + β-TCP (polycaprolactone and beta-tricalcium phosphate), compared to the use of PMMA (polymethyl methacrylate) acrylic cement for bone regeneration in patients undergoing cranioplasty in the city of Valdivia, Chile, between the years 2024-2025. The main beneficiaries will be patients, users of the public or private health system, who require bone regeneration. The intermediate beneficiaries are the health team: doctors specialized in surgery and orthopedics, dedicated in their professional work to bone reconstruction and regeneration.
Trial Details
NCT Number NCT06792864
Lead Sponsor Universidad Austral de Chile
Conditions
(from sponsor)		 Cranioplasty, Craniotomy, Craniotomy Clipping, Craniotomy Surgery, Craniocerebral Trauma, Craniocerebral Injuries
Related terms Craniocerebral Trauma
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov